Harrow Health competitorsClear all
Harrow Health's top competitors include Cour Pharmaceuticals Development, Zhimeng Biopharma, CuraSen Therapeutics and Tarveda Therapeutics.
| Save Comparison |  Harrow Health Harrow Health (formerly Imprimis Pharmaceuticals) is a pharmaceutical company dedicated to delivering high quality and innovative medicines to physicians and patients at accessible prices. |  Cour Pharmaceuticals Development Cour Pharmaceuticals Development is a company developing treatments and cures for immune-mediated diseases. |  Zhimeng Biopharma Zhimeng Biopharma (上海挚盟医药科技有限公司) is a biotech company developing medicines for the treatment of chronic hepatitis B (CHB) and severe neurological diseases. |  CuraSen Therapeutics CuraSen Therapeutics is focused on the discovery and development of therapies to treat neurodegenerative diseases. |  Tarveda Therapeutics Tarveda Therapeutics develops novel cancer therapies created to treat solid tumors. |
Founding Date | Founding Date 2012 | Founding Date 2012 | Founding Date 2017 | Founding Date 2016 | Founding Date 2011 |
Type | Type Public | Type Private | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations San Diego, US HQ Irvine, US Nashville, US Roxbury Township, US | Locations Northbrook, US HQ | Locations HQ | Locations San Mateo, US HQ | Locations Watertown, US HQ |
Employees | Employees 1331% decrease | Employees 284% increase | Employees 12 | Employees 167% increase | Employees 333% decrease |
Twitter followers | Twitter followers 492 | Twitter followers N/A | Twitter followers N/A | Twitter followers 41 | Twitter followers N/A |
Alexa Website Rank | Alexa Website Rank 340883 | Alexa Website Rank 403002 | Alexa Website Rank 427835 | Alexa Website Rank N/A | Alexa Website Rank N/A |
Employee Rating | Employee Rating N/A | Employee Rating 1 | Employee Rating N/A | Employee Rating N/A | Employee Rating N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 17k (almost 8 years ago) | Latest funding round $ 142m (over 1 year ago) | Latest funding round $ 54.5m (over 2 years ago) | Latest funding round $ 30m (about 4 years ago) |
Total funding raised | Total funding raised $ 48.7m | Total funding raised $ 17k | Total funding raised $ 142m | Total funding raised $ 54.5m | Total funding raised $ 158.6m |
For sources of this data, please see the company profile
View company profiles
Cour Pharmaceuticals Development
HQ
Northbrook, US
Employees
28↑ 4% increase
Cour Pharmaceuticals Development is a company developing treatments and cures for immune-mediated diseases.
View companyZhimeng Biopharma
HQ
Employees
12
Zhimeng Biopharma (上海挚盟医药科技有限公司) is a biotech company developing medicines for the treatment of chronic hepatitis B (CHB) and severe neurological diseases.
View companyCuraSen Therapeutics
HQ
San Mateo, US
Employees
16↑ 7% increase
CuraSen Therapeutics is focused on the discovery and development of therapies to treat neurodegenerative diseases.
View companyTarveda Therapeutics
HQ
Watertown, US
Employees
33↓ 3% decrease
Tarveda Therapeutics develops novel cancer therapies created to treat solid tumors.
View company